Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection.
Saved in:
| Title: | Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection. |
|---|---|
| Authors: | Peluso MJ; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA 94110, USA., Ryder D; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA 94110, USA.; Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA 94110, USA., Flavell RR; Department of Radiology, University of California, San Francisco, San Francisco, CA 94158, USA., Wang Y; Department of Radiology, University of California, San Francisco, San Francisco, CA 94158, USA., Levi J; CellSight Technologies, San Francisco, CA 94107, USA., LaFranchi BH; Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA 94110, USA., Deveau TM; Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA 94110, USA., Buck AM; Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA 94110, USA., Munter SE; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA 94110, USA.; Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA 94110, USA., Asare KA; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA 94110, USA.; Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA 94110, USA., Aslam M; Department of Radiology, University of California, San Francisco, San Francisco, CA 94158, USA., Koch W; Department of Radiology, University of California, San Francisco, San Francisco, CA 94158, USA., Szabo G; Department of Pathology, University of California, San Francisco, San Francisco, CA 94143, USA., Hoh R; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA 94110, USA., Deswal M; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA 94110, USA., Rodriguez AE; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA 94110, USA., Buitrago M; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA 94110, USA., Tai V; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA 94110, USA., Shrestha U; Department of Radiology, University of California, San Francisco, San Francisco, CA 94158, USA., Lu S; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA 94158, USA., Goldberg SA; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA 94158, USA., Dalhuisen T; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA 94158, USA., Vasquez JJ; Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA 94110, USA., Durstenfeld MS; Division of Cardiology, University of California, San Francisco, San Francisco, CA 94110, USA., Hsue PY; Division of Cardiology, University of California, San Francisco, San Francisco, CA 94110, USA., Kelly JD; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA 94158, USA., Kumar N; Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA 94110, USA., Martin JN; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA 94158, USA., Gambhir A; CellSight Technologies, San Francisco, CA 94107, USA., Somsouk M; Division of Gastroenterology, University of California, San Francisco, San Francisco, CA 94110, USA., Seo Y; Department of Radiology, University of California, San Francisco, San Francisco, CA 94158, USA., Deeks SG; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA 94110, USA., Laszik ZG; Department of Pathology, University of California, San Francisco, San Francisco, CA 94143, USA., VanBrocklin HF; Department of Radiology, University of California, San Francisco, San Francisco, CA 94158, USA., Henrich TJ; Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA 94110, USA. |
| Source: | Science translational medicine [Sci Transl Med] 2024 Jul 03; Vol. 16 (754), pp. eadk3295. Date of Electronic Publication: 2024 Jul 03. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1946-6242 |
|---|---|
| DOI: | 10.1126/scitranslmed.adk3295 |
